Download AppA quick note before we start: this is general education, not medical advice, and none of it replaces a conversation with your own clinician.
Most people picture migraine on a scale that runs from mild to severe. Clinicians draw one of the most important lines somewhere else entirely, on frequency. How bad a given attack feels matters enormously to the person having it, but whether migraine is called episodic or chronic comes down to a drier question: how many days a month does your head hurt?
Where the line sits
The International Classification of Headache Disorders, third edition, is the reference neurologists actually use. It defines chronic migraine as headache on 15 or more days per month for more than three months, where at least 8 of those days carry the features of migraine, in someone who has had at least five migraine attacks in their life (ICHD-3 1.3). Anything below that 15-day threshold is called episodic migraine (American Migraine Foundation).
It is worth sitting with how arbitrary 15 can feel. Someone with 14 headache days a month and someone with 15 are living nearly identical lives, yet they land on opposite sides of a label. The number is a useful convention, not a biological cliff. What it marks is real, though. Past a certain frequency, migraine tends to change character, gets harder to treat, and takes a different kind of toll.
Episodic is not one thing
"Episodic" covers an enormous range. Two headache days a month and twelve headache days a month are both episodic, and they are nothing alike. Researchers often separate low-frequency from high-frequency episodic migraine, roughly around the 10-day mark, precisely because the high end behaves so differently. People at 10 to 14 headache days a month sit closest to the line, and, as we will see, that is exactly the group most likely to cross it.
How episodic becomes chronic
The shift from episodic to chronic is common enough to have a name, chronification. In large population studies, roughly 2.5 to 3 percent of people with episodic migraine progress to chronic migraine each year (AMPP, Bigal and Lipton; review, 2023). Clinic-based studies report figures as high as 14 percent, but those draw on people already seeking help for difficult headaches, so they overstate the risk for the average person. The honest headline is that migraine gets worse in some people, not most, and none of these numbers is a prediction about any one individual.
What pushes someone across the line? Two factors stand out. The first is simply how many headache days you already have. Ten or more monthly headache days is associated with almost a sixfold higher risk of progression, and this finding rests on solid evidence (review, 2023). The second is overuse of acute medication, linked to a much larger risk, close to nine times, though here the evidence is genuinely weak and the direction of cause is unclear. Frequent headaches lead people to take more medication, so the arrow may point both ways. Treat that number as a flag, not a proven mechanism.
Beyond those two, work with the AMPP study points to a familiar list of modifiable factors: obesity, depression, stressful life events, sleep problems including snoring, and heavy caffeine use (Bigal and Lipton, 2006). These are associations rather than certainties, and caffeine in particular rests on thinner evidence than the rest. They are worth knowing mainly because several are things you and a clinician can actually act on.
The medication trap
Medication overuse earns its own note, because the drugs meant to help can, past a point, keep the headaches coming. That pattern has a name of its own, medication overuse headache. The thresholds that define it are specific: simple painkillers on 15 or more days a month, or triptans, ergots, opioids, and combination painkillers on 10 or more days a month, sustained for more than three months (ICHD-3 8.2). Barbiturate and opioid-based painkillers carry the strongest, most dose-sensitive risk. Triptans and ordinary anti-inflammatory drugs look far safer. A common rule of thumb is to keep acute medication under about 10 days a month, which is a conversation worth having with a prescriber rather than managing on your own.
Crossing the line is not a life sentence
One fact rarely survives into the frightening version of this story. Chronic migraine is not a permanent state. In the AMPP cohort, about a quarter of people with chronic migraine had reverted to episodic migraine when they were followed over two years (Manack and Lipton, Neurology 2011). Frequency moves in both directions, especially once the drivers above are addressed. One honest caveat on that figure: it covers two years, not one, so it is not a quarter of people recovering every twelve months.
None of this is cosmetic. Chronic migraine carries a far heavier load than episodic. Standard disability scores run roughly 5 to 10 times higher, alongside worse quality of life and more depression and anxiety (burden study, 2011). That is exactly why the 15-day line is worth caring about. It is not a word on a chart. It marks the point where earlier, more determined treatment tends to pay off most, and where keeping an eye on your own frequency, the one thing a simple record does well, becomes genuinely useful.
Your monthly headache count is a number worth knowing, tracking, and raising with someone who can act on it. Everything here is general information rather than guidance for your situation, and any decision about medication or treatment belongs with a clinician who knows your history.